36
Participants
Start Date
July 21, 2004
Primary Completion Date
April 1, 2010
Study Completion Date
April 1, 2010
Pirfenidone
Pirfenidone orally as capsules three times a day approximately every 8 hours for cycles of 28 days with no rest period between cycles (28 day treatment cycles); 500 mg/m\^2 every 8 hours (1500 mg/m2/day).
Beth Israel Medical Center, New York
SUNY Upstate Medical University, Syracuse
Childrens Hospital, Pittsburgh, Pittsburgh
Childrens Hospital, Philadelphia, Philadelphia
Childrens National Medical Center, Washington D.C.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
Johns Hopkins Oncology Center, Baltimore
University of Alabama, Birmingham
Cleveland Clinic, Cleveland
Mayo Clinic, Rochester, Rochester
Childrens Memorial Hospital, Chicago, Chicago
St. Louis Children's Hospital, St Louis
Texas Children's Hospital, Houston
Childrens Hospital, Dana-Farber Cancer Institute, Boston
Oregon Health Sciences University, Portland
National Cancer Institute (NCI)
NIH